Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,790
Closed -$417K 713
2024
Q4
$417K Sell
5,790
-578
-9% -$45.2K 0.01% 667
2024
Q3
$519K Buy
6,368
+1,227
+24% +$98.1K 0.02% 593
2024
Q2
$382K Sell
5,141
-271
-5% -$20.3K 0.01% 690
2024
Q1
$422K Buy
5,412
+836
+18% +$62.2K 0.01% 662
2023
Q4
$327K Buy
4,576
+274
+6% +$19.1K 0.01% 710
2023
Q3
$299K Sell
4,302
-151
-3% -$11.4K 0.01% 686
2023
Q2
$361K Buy
4,453
+36
+0.8% +$2.94K 0.01% 675
2023
Q1
$356K Buy
4,417
+413
+10% +$33.2K 0.01% 661
2022
Q4
$300K Buy
+4,004
New +$285K 0.01% 695

Other funds holding HOLX

Bleakley Financial Group's HOLX Position: Q1 2025 in Review

Bleakley Financial Group sold out of Hologic (HOLX) in Q1 2025, closing a stake of 5,790 shares — an estimated $417K sold.

Bleakley Financial Group first reported a position in HOLX in Q4 2022 and held it in 9 quarters. The position peaked at $519K in Q3 2024. 706 funds tracked by Wall St. Rank hold HOLX as of Q1 2025.

  • Bleakley Financial Group reported no remaining Hologic position as of Q1 2025 after selling out during the quarter.
  • Bleakley Financial Group sold 5,790 Hologic shares in Q1 2025, an estimated $417K.
  • Bleakley Financial Group first reported a position in Hologic in Q4 2022 and held it in 9 quarters.
  • Bleakley Financial Group's Hologic position peaked at $519K in Q3 2024.
  • 706 funds tracked by Wall St. Rank held Hologic as of Q1 2025.

Based on Bleakley Financial Group's 13F filing for Q1 2025, filed 1 May 2025.